NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Michael Curry
Harvard University - Cambridge / United States
Medical and Health Sciences / Virology
AD Scientific Index ID: 1388914
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Michael Curry's MOST POPULAR ARTICLES
1-)
Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosisMP Curry, JG O’Leary, N Bzowej, AJ Muir, KM Korenblat, JM Fenkel, ...New England Journal of Medicine 373 (27), 2618-2628, 20159062015
2-)
Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver diseaseM Charlton, GT Everson, SL Flamm, P Kumar, C Landis, RS Brown Jr, ...Gastroenterology 149 (3), 649-659, 20159052015
3-)
Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infectionM Bourlière, SC Gordon, SL Flamm, CL Cooper, A Ramji, M Tong, ...New England Journal of Medicine 376 (22), 2134-2146, 20175942017
4-)
Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label studyMP Curry, X Forns, RT Chung, NA Terrault, R Brown Jr, JM Fenkel, ...Gastroenterology 148 (1), 100-107. e1, 2015485*2015
5-)
Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantationM Charlton, E Gane, MP Manns, RS Brown Jr, MP Curry, PY Kwo, ...Gastroenterology 148 (1), 108-117, 2015479*2015
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept